2023 annual financial data
Dianthus Therapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,304.35%.
Operating income was -48,174,000 USD and net income was -43,555,000 USD.
Operating cash flow was -36,861,000 USD.
Get free Dianthus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,826,000 USD
- Operating income
- -48,174,000 USD
- Net income
- -43,555,000 USD
- Operating cash flow
- -36,861,000 USD